Home Compare BMY vs GSK.L
Stock Comparison · Industry comparison · Drug Manufacturers - General

Bristol-Myers Squibb Company vs GSK: Which Stock Looks Stronger in 2026?

GSK holds the cleaner structural position, with the lead spread across profitability and stability. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (BMY: Russell 1000, GSK.L: STOXX 600).

Updated 2026-05-17

The lead is spread across profitability and stability, rather than sitting in one isolated gap. The overall score gap is 10 points in favour of GSK plc.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. BMY and GSK.L share the same industry classification.

For a similarity-based comparison, see how BMY and GSK each position within their functional peer groups in AssetNext.

Peer-Relative Score
BMY
Bristol-Myers Squibb Company
57
Peer-Score
Signal qualitylow
Peer basis: Russell 1000
vs
GSK.L
GSK plc
67
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BMY vs GSK.L Profitability 45 68 Stability 59 76 Valuation 87 84 Growth 27 30 BMY GSK.L
Gap Ranking
#1 Profitability +23
#2 Stability +17
#3 Growth +3
#4 Valuation +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMY and GSK.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMYGSK.L Relative valuation Structural strength

Neither company combines the stronger profile with the cheaper valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both profiles are strong on profitability, but GSK plc leads clearly.
Stability
On stability, the same pattern holds: both rank well, but GSK plc still sits higher.
Profitability — Dominant Gap
BMY
45
GSK.L
68
Gap+23in favour of GSK.L

Capital efficiency adds support, with a 5.4-point ROIC advantage.

What keeps the gap from being one-sided

Bristol-Myers Squibb Company still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BMY vs GSK.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-stability comparisons

Explore how BMY and GSK.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.